Get a glimpse into our company and investor data—powered by the PitchBook Platform
National Research Institute
Buyout/LBOLATEST DEAL TYPE
Provider of clinical research services. The company conducts late-phase clinical research trials on behalf of pharmaceutical and biotechnology drug developers in principally metabolic disease states undergoing testing for FDA approval.